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INTESTINAL MICROBIOTA AND THE CONTROL OF GLUCOSE
HOMEOSTASIS AND LIPID METABOLISM IN THE HOST
The human intestinal microbiota is dominated by five phyla: Firmicutes, Bacteroidetes,
Actinobacteria, Proteobacteria, and Verrucomicrobia. In adults, more than 80% of the species
belong to just two phyla, Firmicutes and Bacteroidetes. Short chain fatty acids (SCFA) are catabolic
end-products from intestinal microbial fermentation. Acetate, propionate and butyrate are the
most abundant (Ríos-Covián et al., 2016a) whilst branched chain fatty acids (BCFA; isobutyrate,
valerate, and isovalerate), the organic acids lactate, succinate, formate, and gases, can be also
formed.
In humans, the main fermentable sources of SCFA are undigested dietary polysaccharides;
amino acids and proteins may constitute additional substrates for colonic fermentation, whereas
host-derived glycoproteins contribute to a limited extent. BCFA can be formed at considerably
lower proportions than SCFA from branched-chain amino acids (BCAA; valine, leucine, and
isoleucine). Threonine renders propionate and butyrate, whereas glutamate, histidine, lysine,
arginine, and alanine give rise to acetate and butyrate formation; additionally, the intestinal
microbiota contributes to the production of amino acids available to the host through de novo
biosynthesis (Neis et al., 2015). Moreover, metabolic cross-feeding, that is the utilization of end
products from the carbohydrate catabolism of a given microorganism by another one, strongly
influences the final balance of intestinal SCFA. It occurs mainly for the formation of butyrate from
acetate or lactate, is considerably lower for butyrate conversion to propionate, and very scarce
between propionate and acetate (Den Besten et al., 2013).
Intestinal SCFA can incorporate into the enterohepatic circulation, being metabolized in the
liver and reaching other extra-intestinal locations (Den Besten et al., 2014). Increasing evidence
supports a regulatory role for SCFA in glucose homeostasis and lipid metabolism, in which
intestinal SCFA ligands FFAR2 and FFAR3 and the glucagon-like peptide are involved. In the liver
propionate is gluconeogenic whereas acetate and butyrate are lipogenic. Recent studies evidence
that propionate and butyrate activate the intestinal gluconeogenesis (De Vadder et al., 2014),
the glucose synthesized serving as a homeostatic signal in the portal system, to control hepatic
gluconeogenesis (causal factor of insulin resistance and type 2 diabetes) and improving whole-
body glucose homeostasis. Moreover, propionate flux through the liver reduces visceral and liver
fat by decreasing intrahepatic triglycerides (Chambers et al., 2015). Propionate inhibits hepatic
lipogenesis and cholesterogenesis promoted by acetate (Demigne et al., 1995) whereas propionate
and butyrate inhibit lipolysis and lipogenesis and increase the incorporation of glucose mediated
by insulin into the adipose tissue (Heimann et al., 2015). These observations prompt to the
acetate/propionate ratio as an indicator for the potential contribution of intestinal SCFA to body
lipid metabolism. Additionally, the improvement of glucose homeostasis promoted by dietary fiber
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seems to be associated with elevated fluxes of SCFA from the
intestinal lumen to other organs rather than with the fecal SCFA
concentrations (Den Besten et al., 2014).
Several metabolic disorders as obesity, insulin resistance,
and metabolic syndrome are associated with impairment of the
metabolism of carbohydrates and lipids by the host, and are
accompanied by changes in the gut microbiota (Turnbaugh et al.,
2009; Bervoets et al., 2013). Higher levels and altered patterns of
SCFA (Fernandes et al., 2014; Salazar et al., 2015) and changes
in the Firmicutes to Bacteroidetes ratio, have been repeatedly
reported in obese individuals (Ley et al., 2006; Turnbaugh et al.,
2006). Nonetheless, contradictory results published so far on the
relative abundance of both phyla exclude its use as a broadly
applicable marker.
Increases in plasma circulating BCAA and aromatic amino
acids (phenylalanine and tyrosine) were related with higher risk
of type 2 diabetes and insulin resistance (Utzschneider et al.,
2016), having been suggested that the altered functionality of
the intestinal microbiota (also affecting de novo biosynthesis of
amino acids) determines these differential profiles of circulating
amino acids (Neis et al., 2015).
Increasing protein intake (Pillot et al., 2009) and gastric
surgery (Liou et al., 2013) have demonstrated efficacy for weight
control and improvement of glucose homeostasis, partly related
to the increase of propionate (De Vadder et al., 2014), and
enrichment of intestinal Bacteroidetes/Bacteroides (Furet et al.,
2010; Jumpertz et al., 2011; Liou et al., 2013). In contrast, a
significant reduction in butyrate and certain butyrate-producing
Firmicutes have been associated with diets containing low
amounts of fiber and carbohydrates (Duncan et al., 2007, 2008;
Walker et al., 2011). These suggest a microbiota unbalance
in obese subjects, or under inadequate diets, which is partly
restored following gastric surgery or by introducing weight-loss
diets. However, some microbiome alterations seem to persist
after dietary interventions, facilitating post-dieting weight regain
(Thaiss et al., 2016). This stresses the importance of achieving
a full restoration of the intestinal microbiota after dietary
treatments, including proper balanced microbial metabolic
products, to ensure durable effects.
A FOCUS ON THE GENUS BACTEROIDES
AND THE PRODUCTION OF PROPIONATE
IN THE INTESTINAL MICROBIAL
ECOSYSTEM
The order Bacteroidales is the most abundant Gram-negative
bacteria, colonizing the human gut at densities up to 5–8
× 1010 CFU per gram of feces (Zitomersky et al., 2011).
Among the predominant genera are Bacteroides and Prevotella.
These microorganisms can use a wide range of dietary soluble
polysaccharides that are firstly released from vegetable fiber in the
intestine by microbial primary degraders (Martens et al., 2011).
The genus Bacteroides displays a high flexibility to adapt to the
nutritional conditions of the intestinal environment (Comstock
and Coyne, 2003), being able to use dietary or host-derived
glycans according to the nutrient availability (Sonnenburg et al.,
2005). Bacteroides can also incorporate amino acids from outside
(Smith and MacFarlane, 1998) which could be used to maintain
cell structures and as an energy source.
Three different biochemical pathways have been identified in
colonic bacteria for propionate formation (Reichardt et al., 2014).
The succinate pathway is the only one for propionate production
from hexoses by Bacteroidetes, although some Negativicutes
(family Veillonellaceae, phylum Firmicutes) can form propionate
by utilizing succinate. The acrylate pathway is used for the
conversion of lactate into propionate by very few bacterial genera
within the phylum Firmicutes, whereas deoxy-sugars (fucose
and rhamnose) are converted through the propanediol pathway
by some Proteobacteria and members of the Lachnospiraceae
family (phylum Firmicutes). Akkermansia muciniphila (phylum
Verrucomicrobia) has been identified as a key propionate
producing mucin-degrading species (Derrien et al., 2004).
Notably, several studies point to Bacteroidetes as the largest
propionate producers in the human gut (Salonen et al., 2014;
Aguirre et al., 2016). Interestingly, by modifying microbiota
composition with antibiotic treatment in mice, Zhao et al. (2013)
found a strong correlation between fecal levels of SCFA and the
abundance of Bacteroides and other members of the phylum
Bacteroidetes.
THE TYPE OF CARBOHYDRATES AND
AVAILABILITY OF ORGANIC NITROGEN
SOURCES MODIFY IN VITRO THE
METABOLISM OF BACTEROIDES
SCFA and organic acids formed in cultures of Bacteroides
(acetate, succinate, lactate, and propionate) depend on the
type of fermentable substrates, generation time and incubation
period (Kotarski and Salyers, 1981; Rios-Covian et al., 2013,
2015, 2016b). Propionate is generally favored at long generation
times, with complex carbohydrates, and under carbon source
limitation.
We have studied the metabolism of Bacteroides fragilis
growing in media containing different carbohydrates and
nitrogen sources. Catabolic end-products formed in the presence
of carbohydrates in non-defined peptone and yeast extract
containing medium (BM; Rios-Covian et al., 2015) with respect
to a minimal medium without no organic nitrogen source
(MM; Rios-Covian et al., 2016b) evidenced higher SCFA and
organic acids production in the former medium, when it was
supplemented with bacterial exopolysaccharides (EPS), which are
complex structures synthesized by some bacteria (Figure 1A).
Acetate accounted for 30–54% of the total products formed in
any condition, constituting a fundamental way for obtaining
energy by this bacterium. An inverse correlation was found
between the production of propionate plus succinate and that
of lactate (Rios-Covian et al., 2015, 2016b; Figure 1A), this last
being favored in the absence of organic nitrogen sources and with
rapid fermentable carbohydrates, as occurs in MM added with
glucose. Conversely, a shift toward propionate formation appears
to occur in the presence of organic nitrogen when EPS are
present. This probably reflects a preferential use of the glucolytic
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FIGURE 1 | The metabolic versatility of Bacteroides and the modulation of its metabolism through diet may impact human health. (A) The relative
proportions of the different organic acids and SCFA produced by cultures of Bacteroides fragilis at 24 h of incubation in non-defined peptone and yeast extract
containing medium (BM; Rios-Covian et al., 2015) and in minimal medium without no organic nitrogen source (MM; Rios-Covian et al., 2016b) and supplemented with
glucose, or with exopolysaccharides produced by Bifidobacterium strains (EPS E44 and EPS R1), are represented in shaded circles. The table at the top right side
indicates total concentration (mM) of SCFA plus organic acids produced by B. fragilis in the different culture conditions. (B) Schematic representation of
(Continued)
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FIGURE 1 | Continued
catabolic routes for the formation of SCFA and organic acids by B. fragilis. Thick bold arrows indicate pathways probably favored in MM supplemented with glucose
(left side) or in BM supplemented with bacterial EPS (right side). (C) Schematic representation of the general hypothesis on how re-shaping the intestinal Bacteroides
metabolism through the adequate balance of dietary proteins and carbohydrates could influence human health. On the one hand, changes occurring in the profile of
SCFA and organic acids produced by this bacterium could act on the host carbohydrates and lipids metabolism directly or through cross-feeding or other microbial
interaction mechanisms. On the other hand, the metabolism of intestinal Bacteroides may modify blood circulating amino acids in the host, which have been related
with some metabolic disorders. OAA, oxaloacetate; SCFA, short chain fatty acidis; BCAA, branched chain amino acids; PEP, phosphoenolpyruvate.
pathway and acetate formation for obtaining energy and keeping
redox balance by B. fragilis in the presence of rapidly fermentable
carbohydrates; in contrast, when complex/slowly fermentable
carbohydrates are available and amino acids are present, carbon
skeletons from amino acids could be incorporated at the level of
pyruvate; in such conditions the propionate-succinate pathway
seems to be potentiated as a way for energy obtaining whilst
serving to restore cell redox balance (Rios-Covian et al., 2015;
Figure 1B). Proteomics and gene expression analyses reinforced
the hypothesis of the activation of amino acids catabolism and
the succinate pathway in B. fragilis grown in BM with EPS
(Rios-Covian et al., 2015). Therefore, the preferential metabolic
route for energy production and redox maintaining, and the
final metabolic products formed by B. fragilis, may be largely
dependent on carbohydrates and nitrogen sources available.
These results suggest the possibility of regulating the metabolism
of Bacteroides by controlling dietary carbohydrate/protein
balance.
Moreover, when analyzing the amino acids in cultures of B.
fragilis added with different carbohydrates, we found a decrease
in the concentration of leucine, isoleucine and phenylalanine
after incubation in any condition, whereas valine and tyrosine
showed much less increases or slight decreases in EPS as
compared to glucose (Supplementary Material Table 2 in Rios-
Covian et al., 2015). This points to a potential capacity of B.
fragilis (as may probably occur with other Bacteroidetes) for
regulating BCAA and aromatic amino acids levels in its growth
environment.
MODULATION OF THE INTESTINAL
BACTEROIDES BY DIETARY
CARBON/NITROGEN SOURCES: A TOOL
FOR RESTORING THE INTESTINAL
MICROBIOTA METABOLIC BALANCE
Under sufficient organic nitrogen, the mildly acidic pH (5.5)
stimulates butyrate producing species in the human colon
curtailing the growth of Bacteroides that was however maximized
at pH 6.5 (Walker et al., 2005). The pH in the caecum is
about 5.7 but gradually increases to 6.7 in the rectum. Dietary
fiber fermentation promotes a slight decrease of the luminal
pH whereas high protein/amino acids fermentation, favored
by low carbohydrate availability, causes slightly pH increases
(Smith and MacFarlane, 1998). Interestingly, a recent study with
mice demonstrated that diet-microbiome interactions are driven
by the pattern of protein and carbohydrate intake (Holmes
et al., 2017). Moreover, some experiments with gnotobiotic
mice support shifts in Bacteroides metabolic functions as a
response to dietary changes (McNulty et al., 2013; Wu et al.,
2015).
The studies just commented support the interdependence
between diet, gut microbiome and host metabolism, and allow
to hypothesize that the combination of dietary organic nitrogen
sources with appropriate carbohydrates may be used to modify
the metabolic activity of colonic Bacteroides populations by
modifying the profile of organic acids formed and enhancing
propionate formation in some parts of the large intestine while
promoting shifts toward healthier profiles of serum amino acids
(Figure 1C).
Within this “scenario,” the potential role that the functional
control and metabolic reprogramming of Bacteroides through
diet may play in the regulation of the host metabolism deserves
more attention. It is essential to decipher to what extent organic
nitrogen sources and carbohydrates could affect the different
species of prominent intestinal bacteria, such as the genus
Bacteroides. An important question raised is whether changes
in SCFA and organic acids profile induced by remodeling
the metabolic activity of Bacteroides through adequate dietary
interventions would influence other less nutritionally versatile
gut beneficial microbes through the enhancement of cross-
feeding or other microbial interaction mechanisms. Omics,
including metabolomics/metabonomics, applied to the analysis
of microbial cultures, animal models, and human samples are
necessary for understanding host and microbiota metabolic
remodeling as a response to dietary combinations of organic
nitrogen/carbohydrates.
The potential to re-shape the metabolism of Bacteroides
with specific combinations of dietary carbohydrates-proteins
based on their composition, structure and availability in the
gut, merits further study. The final aim should be designing
diets based on nutrient components targeted at modulating
the metabolism of Bacteroides, which may interact with other
intestinal beneficial microbes, in order to restore the metabolic
balance of the microbiota to promote durable host’s health
effects.
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